A Randomized Comparison of Personalized Therapy Mgmt Based On Coronary Atherosclerotic Plaque Vs. Usual Care for Symptomatic Patients With Suspicion of CAD

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 1000 participants.

Also called NCT06713239

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 1,000 participants (planned count) (from the registry)
Sponsor
Cleerly, Inc. (from the registry)
Registry
  • NCT NCT06713239
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT06713239. Randomized; no masking; primary purpose diagnostic. Start 2024-12-18 (actual); primary completion 2026-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Randomized Comparison of Personalized Therapy Mgmt Based On Coronary Atherosclerotic Plaque Vs. Usual Care for Symptomatic Patients With Suspicion of CAD
Acronym
PARAMOUNT
Intervention (Device)
Cleerly Labs and Cleerly ISCHEMIA
Lead sponsor
Cleerly, Inc. (class: industry)

Record details

Record id
cardio:ct-nct06713239
Content hash
5c9edef1175f35a786bb09621170bce264522e10a77eba58536efb95a6c40ba3